Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients Ang HuangBo ZhangYa-Jun Guo Original Article 13 June 2013 Pages: 1439 - 1451
Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue Anna M. SherwoodRyan O. EmersonHarlan Robins Original Article 16 June 2013 Pages: 1453 - 1461
Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion Sara FritzellEmma SandénPeter Siesjö Original Article 18 June 2013 Pages: 1463 - 1474
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis Bridget CharbonneauAlice H. WangJames R. Cerhan Original Article 28 June 2013 Pages: 1475 - 1484
Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer Anneke NeumannHelen HörzerStefan Stevanović Original Article 02 July 2013 Pages: 1485 - 1497
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma Einar Osland Vik-MoMarta NyakasIver A. Langmoen Original Article Open access 02 July 2013 Pages: 1499 - 1509
Vaccination of castration-resistant prostate cancer patients with TroVax (MVA–5T4) in combination with docetaxel: a randomized phase II trial Richard HarropFranklin ChuAnna Ferrari Original Article 23 July 2013 Pages: 1511 - 1520
Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer James L. GulleyChristopher R. HeeryPeter A. Pinto Original Article 09 July 2013 Pages: 1521 - 1531
Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models Maria Jure-KunkelGregg MastersRachel Humphrey Original Article Open access 20 July 2013 Pages: 1533 - 1545
